drugset / Trial / NCT00171847
Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer
Phase 4
Terminated
93 enrolled
Novartis Pharmaceuticals
Roche - Prof. Dr. Jens Huober et al. · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Phase IV trial to investigate the effect of the combination of Letrozole with trastuzumab in metastatic breast cancer patients
Timeline
- Start
- 2003-03
- Primary completion
- 2008-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Letrozole | Other / unclassified | — | — |
| Subject | Trastuzumab | Monoclonal antibody | — | — |